Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge-Reference-Cited by-同舟云学术

Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge

Published:2022-01 Issue: Volume:229 Page:107924
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Lavacchi Daniele,Landini Ida,Perrone Gabriele,Roviello Giandomenico,Mini Enrico,Nobili Stefania

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference112 articles.

1. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): A multicentre seamless design study;Abramson;Lancet,2020

2. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells;Aebi;Clinical Cancer Research,1997

3. The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab;Ahlgrimm;Blood,2011

4. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis;Alas;Clinical Cancer Research,2001

5. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the PDK4-centered rituximab-resistant mechanism in DLBCL: the potential of the “Smart” exosome nanoparticle therapy;Molecular Cancer;2024-07-15

2. Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients;Cancer Drug Resistance;2024-05-24

3. S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma;Frontiers in Oncology;2024-02-01

4. Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century;Annals of Hematology;2024-01-16

5. Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics;Advances in Pharmacological and Pharmaceutical Sciences;2024-01